- Home
- BCYC vs NAGE Comparison
BCYC vs NAGE Comparison
Compare BCYC & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCYC | NAGE |
|---|---|---|
| Founded | 2009 | 1999 |
| Country | United Kingdom | United States |
| Employees | N/A | 117 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.8M | 261.2M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | BCYC | NAGE |
|---|---|---|
| Price | $4.12 | $3.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | $13.90 | ★ $16.00 |
| AVG Volume (30 Days) | 281.0K | ★ 782.7K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $16.51 |
| Revenue Next Year | N/A | $14.58 |
| P/E Ratio | ★ N/A | $21.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.75 | $2.87 |
| 52 Week High | $9.16 | $10.52 |
Technical Indicators
Market Signals| Indicator | BCYC | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 51.63 | 40.71 |
| Support Level | $3.94 | N/A |
| Resistance Level | $4.52 | $3.60 |
| Average True Range (ATR) | 0.15 | 0.16 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 77.89 | 21.19 |
Price Performance
Historical ComparisonAbout BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.
About NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.